GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) Institutional Ownership

CUSIP: M47238122

13F Institutional Holders and Ownership History from Q2 2023 to Q3 2024

Type / Class
Equity / SHS NEW
Symbol
GLMD on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP M47238122?
CUSIP M47238122 identifies GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$99,436 0
2024 Q2 396,731 $112,946 +$62,648 $0.28 11
2024 Q1 172,456 $57,609 -$128,564 $0.35 11
2023 Q4 546,788 $248,791 -$74,579 $0.46 12
2023 Q3 691,438 $429,211 +$74,839 $0.62 16
2023 Q2 143,537 $419,148 +$419,148 $2.99 12